GlassScriptPhysician profile
Michael A Savitt
NPI 1609838184
$7,320.85
in general payments reported to CMS, 2019-2025
12 companies · $1,346 in 2025
The $1,346 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $1,700 · 2021: $481 · 2022: $3,281 · 2023: $152 · 2024: $134 · 2025: $1,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,632.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,223.63 | 2022 | |
| Medtronic Vascular, INC. | $1,364.81 | 2020 | |
| Medtronic, INC. | $657.14 | 2021-2025 | Avalus, Penditure |
| Abiomed | $412.03 | 2024-2025 | Impella |
| Ethicon US, LLC | $376.49 | 2020-2023 | Echelon Endopath, Vistaseal |
| Getinge USA Sales, LLC | $344.27 | 2021-2023 | Vasoview Hemopro 2 |
| La Jolla Pharmaceutical Company | $227.00 | 2019 | |
| Edwards Lifesciences Corporation | $214.73 | 2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $175.11 | 2025 | Epic |
| Lexington Medical, INC. | $144.20 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Cvrx, INC. | $107.76 | 2025 | Barostim Neo System |
| Zimmer Biomet Holdings, INC. | $73.68 | 2023 | Sternalock Blu System, Advantagerib |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Savitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.